Sexually transmitted diseases (STDs) are infections spread from one individual to another, mainly through sexual contact. Some of these diseases are curable, while others are not. Chlamydia is a curable infection that can be treated effectively with antibiotics. On the other hand, an acquired immunodeficiency syndrome (AIDS) is a disease that cannot be cured with medicines. These diseases are mainly caused by infectious agents, usually passed through sex.
AIDS and chlamydia are diseases caused by different infectious agents. The causative agent to chlamydia is a bacteria known as Chlamydia trachomatis (Katzman et al., 2019). The bacteria can spread from one individual to another through vaginal, oral, or anal sex. However, AIDS is caused by the human immunodeficiency virus (HIV). The virus affects an individual’s immune system, which makes it harder for the body to infections and diseases.
Whether or not an STD can be cured depends on the type of infectious agent. Antibiotics can treat an STD caused by Chlamydia trachomatis (Katzman et al., 2019). In addition, it is strongly suggested that the infected person should not have sexual contact while getting treatment. Unfortunately, AIDS cannot be cured because it is caused by a virus. However, it can be controlled with the right medical care.
AIDS is a contagious disease if appropriate precautions are not considered. If the person with the disease gets good treatment, this can help stop the disease from spreading. However, if an individual with the disease fails to get treatment and does not take care of themselves by not sharing needles or not wearing a condom, then they could spread the disease. AIDS becomes contagious when patients fail to adhere to a medical advisory.
The most appropriate way for people to protect themselves from AIDS is abstinence, protected sex, and practicing other preventive measures. Other ways to avoid getting the disease include getting tested and treated for other STDs ahead of time and regularly, for example, every three months after possible contact with a positive person. In addition, an individual needs to be cognizant of the healthcare provider’s advisory regarding prevention practices.
Reference
Katzman, C., Mateu-Gelabert, P., Kapadia, S. N., & Eckhardt, B. J. (2019). Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination. International Journal of Drug Policy, 72, 33-39. Web.